Microparticle formation in apheresis platelets is not affected by three leukoreduction filters

Transfusion

Volumn 53, Issue 10, 2013, Pages 2293-2298

  Nollet, Kenneth E ^a   Saito, Shunnichi ^a   Ono, Takako ^a   Ngoma, Alain ^a   Ohto, Hitoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD FILTRATION; BLOOD FLOW; BLOOD GROUP ABO SYSTEM; BLOOD SAMPLING; BLOOD STORAGE; ERYTHROCYTE; ERYTHROCYTE DERIVED MICROPARTICLE; FLOW CYTOMETRY; HUMAN; LEUKAPHERESIS; LEUKOCYTE MICROPARTICLE; MALE; MEMBRANE MICROPARTICLE; PLATELET MICROPARTICLE; TEMPERATURE; THROMBOCYTOPHERESIS;

BLOOD PRESERVATION; CELL-DERIVED MICROPARTICLES; FLOW CYTOMETRY; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MALE; PLATELETPHERESIS;

EID: 84885848789     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12088     Document Type: Article

References (20)

1. Alonso-Echanove J, Sippy BD, Chin AE, Cairns L, Haley R, Epstein JS, Richards MJ, Edelhauser H, Hedberg K, Kuehnert MJ, Jarvis WR, Pearson ML,. Nationwide outbreak of red eye syndrome associated with transfusion of leukocyte-reduced red blood cell units. Infect Control Hosp Epidemiol 2006; 27: 1146-1152. (Pubitemid 44807455)
2. Alvarado-Ramy F, Kuehnert MJ, Alonso-Echanove J, Sledge L, Haley NR, Epstein J, Vostal J, Pearson M,. A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter. Transfus Med 2006; 16: 41-48.
3. Moore SB,. Hypotensive reactions: are they a new phenomenon? Are they related solely to transfusion of platelets? Does filtration of components play a role? Transfusion 1996; 36: 852-853.
4. Abe H, Ikebuchi K, Shimbo M, Sekiguchi S,. Hypotensive reactions with a white cell-reduction filter: activation of kallikrein-kinin cascade in a patient. Transfusion 1998; 38: 411-412; author reply 413-5.
5. Shakespeare W,. The Tempest: Act 2, Scene 1, Verse 279, circa 1610.
6. Tan KT, Tayebjee MH, Lim HS, Lip GYH,. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Diabet Med 2005; 22: 1657-1662. (Pubitemid 43046464)
7. Nomura S,. Function and significance of platelet-derived microparticles. Int J Hematol 2001; 74: 397-404.
8. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet J-M,. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006; 26: 2594-2604.
9. Lynch SF, Ludlam CA,. Plasma microparticles and vascular disorders. Br J Haematol 2007; 137: 36-48. (Pubitemid 46426401)
10. Simak J, Gelderman MP,. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20: 1-26. (Pubitemid 41811224)
11. Keuren JF, Magdeleyns EJ, Bennaghmouch A, Bevers EM, Curvers J, Lindhout T,. Microparticles adhere to collagen type I, fibrinogen, von Willebrand factor and surface immobilised platelets at physiological shear rates. Br J Haematol 2007; 138: 527-533. (Pubitemid 47063021)
12. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J,. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 2006; 134: 307-313. (Pubitemid 43990792)
13. Sugawara A, Nollet KE, Yajima K, Saito S, Ohto H,. Preventing platelet-derived microparticle formation-and possible side effects-with prestorage leukofiltration of whole blood. Arch Pathol Lab Med 2010; 134: 771-775.
14. Kitazawa J, Nollet K, Morioka H, Tanaka K, Inomata M, Kubuki Y, Ohto H,. Non-D Rh antibodies appearing after apheresis platelet transfusion: stimulation by red cells or microparticles? Vox Sang 2011; 100: 395-400.
15. Nomura S, Inami N, Fujita S, Ozasa R, Higashi S, Nagai Y,. Proposal of standardization for micro-particle determination by flow cytometer. Cytometry Res 2011; 20: 71-84.
16. Ozeki Y, Nomura S,. Assay methods for platelet-derived microparticle: merit and problem. Jpn J Thromb Hemost 2004; 15: 286-292.
17. Nollet KE, Sugawara A, Saito S, Yajima K, Miura M, Yokomizu T, Ohto H,. Combined prion and leukocyte (PR*LR) filters vary with respect to vesicle formation during storage. Transfus Med 2009; 20: 215-216.
18. Triulzi DJ, Dzik WH,. Leukocyte-reduced blood components: laboratory and clinical aspects. In:, Simon TL, Dzik WH, Snyder EL, Stowell CP, Strauss RG, editors. Rossi's principles of transfusion medicine. West Sussex, UK: John Wiley & Sons; 2009. p. 228-246.
19. Dzik S,. Leukodepletion blood filters: filter design and mechanisms of leukocyte removal. Transfus Med Rev 1993; 7: 65-77. (Pubitemid 23115838)
20. Sharma RR, Marwaha N,. Leukoreduced blood components: advantages and strategies for its implementation in developing countries. Asian J Transfus Sci 2010; 4: 3-8.